FDA
approval
· 2021-06-04
FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approves Lupin Pharmaceuticals' generic fixed-dose combination emtricitabine and tenofovir disoproxil fumarate (emtricitabine/tenofovir DF) under an origina…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)